Lotus Clinical Research, a full-service, consultative contract research organization (CRO), entered into a strategic partnership with Trialogics, a clinical trial software company, to expand Lotus’ use of Trialogics’ clinical trial software offerings. This collaboration will build upon enhancements made to data collection methods, streamline trial processes, and strengthen the quality of data collection.

With the increased use of ePRO and more complicated randomization schemes, Lotus said that it needed to find a partner with a highly customizable and easily modifiable solution, to suit their client’s needs. After working with Trialogics across numerous trials and benefiting from the functionality and responsiveness of the Trialogics team, the decision was made to further grow the existing relationship.

Trialogics provides the flexibility to collect data via a cloud-based platform or through various mobile devices. This helps to provide tailored solutions that support efficient and reliable data collection and sharing.

Bill Martin, Lotus Clinical Research President, said, “Partnering with Trialogics has allowed us to seamlessly support data collection and has enabled centralized review of interview-based questionnaires. This has helped to reduce interview bias across our trials, a critical factor in CNS studies. Additionally, Trialogics’ suite of services, including randomization and drug supply management, has optimized processes and improved the quality of our trial delivery.”

“We have been working with Lotus Clinical for several years and have developed a great relationship while delivering exceptional services. Expansion of this strategic partnership will enable us to offer additional integrated solutions to their sponsors,” said Chris Gropp, CEO, Trialogics. “As technology becomes more of a focus in clinical trials, the need for these partnerships grows.”